Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogeneic hematopoietic stem cell transplantation: current issues and future prospects.

G Socié1, E Gluckman

  • 1Service de Greffe de Moelle, Hôpital Saint-Louis, Paris, France. gsocie@chu-stlouis.fr

Annales De Medecine Interne
|February 25, 2000
PubMed
Summary

Hematopoietic stem cell transplantation has evolved into an established therapy for various disorders and malignancies. Advances have reduced transplant-related mortality, broadening its clinical applications and improving patient survival outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.

Annals of the rheumatic diseases·2007
Same author

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

Bone marrow transplantation·2007
Same author

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.

Bone marrow transplantation·2007
Same author

Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.

Bone marrow transplantation·2007
Same author

[Clinical research at the European LeukemiaNet].

Deutsche medizinische Wochenschrift (1946)·2006

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Hematopoietic stem cell transplantation (HSCT) has progressed significantly since its inception.
  • Once experimental, HSCT is now a standard treatment for hematologic disorders and malignancies.
  • Decreased transplant-related mortality has expanded the eligibility criteria for HSCT.

Purpose of the Study:

  • To review current challenges and future directions in allogeneic stem cell transplantation.
  • To discuss key aspects including stem cell sources, donor options, and GVHD.
  • To examine evolving indications and long-term survival post-transplant.

Main Methods:

  • Literature review of recent advancements in allogeneic stem cell transplantation.
  • Synthesis of current data on stem cell sources and alternative donor strategies.

Related Experiment Videos

  • Analysis of graft-versus-host disease (GVHD) management and prevention.

    • Main Results:

    • Allogeneic HSCT is a well-established therapeutic modality with expanding indications.
    • Reduced mortality rates are attributed to improved supportive care and conditioning regimens.
    • Ongoing research focuses on optimizing stem cell sources and mitigating GVHD.

    Conclusions:

    • Allogeneic stem cell transplantation offers significant therapeutic benefits for various conditions.
    • Future prospects involve refining techniques, expanding donor pools, and enhancing long-term patient outcomes.
    • Continued research is crucial for further improving the safety and efficacy of HSCT.